Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Applying a sustainable mindset can offer a competitive advantage in both the industry and the community.
May 2, 2022
By: Henryk Badack
Senior VP Technical Service and Internal Project Management Vetter Pharma-Fertigung GmbH & Co. KG
Successful companies with high reputations are expected to be financially stable but socially responsible as well. That means using natural resources whenever possible and meeting high ethical standards. In short, companies should act in a sustainable manner, doing all that they can to support our climate. It is important that all effort be made to live within the earth’s natural restrictions and accept the boundaries and limitations of its ecosystem. But, how can we balance these needs? After all, everyone is environmentally responsible for any actions that threaten the planet we inhabit. For today’s pharma and biotech companies and their partner networks, adopting this mindset can mean a competitive advantage in both the industry and the community. While drug companies manufacture medications that are necessary for improving the quality of life for patients around the world, many of which are lifesaving, their production is, nevertheless, resource intensive. As an industry, pharmaceutical manufacturing requires a great deal of energy-intensive production operations including automated air circulation and a high water and electricity usage to name but a few. Also, the required high standards that result from strict, ever-increasing, and absolute binding regulations by healthcare authorities make it not that easy to entirely avoid residual emissions. Another requirement facing the drug manufacturing industry is the “Green Deal.” Initiated by the European Union, it sets a climate goal to be the “world’s first climate-neutral continent” by 2050, thus cutting greenhouse gas emissions by more than half by 2030. For the biopharma industry, a delicate balance must be achieved. On the one hand, its players must, of course, continue to strictly achieve the high regulatory requirements and, on the other hand, strive to enable environmentally friendly usage of resources to contribute meeting the Green Deal climate goal. How can these goals best be met?
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !